Thermo Fisher Scientific (MEX:TMO) Short-Term Debt: MXN58,768 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:TMO Thermo Fisher Scientific Inc MEX:TMO
79 GF Score
Price MXN10,254.00
GF Value MXN10,156.88
Valuation Fairly Valued
! 10 Warning Signs
View Full Analysis

What is Thermo Fisher Scientific Short-Term Debt?

Thermo Fisher Scientific MEX:TMO +3.79% 79 Short-Term Debt is MXN58,768 Mil as of Jun. 2026. GuruFocus rates MEX:TMO with a GF Score™ of 79/100 and a GF Value™ of MXN10,156.88 (Fairly Valued). The stock has 10 warning signs investors should review.

Thermo Fisher Scientific's Short-Term Debt for the quarter that ended in Jun. 2026 was MXN58,768 Mil.

Thermo Fisher Scientific's quarterly Short-Term Debt declined from Dec. 2025 (MXN63,614 Mil) to Mar. 2026 (MXN55,721 Mil) but then increased from Mar. 2026 (MXN55,721 Mil) to Jun. 2026 (MXN58,768 Mil).

Thermo Fisher Scientific's annual Short-Term Debt declined from Dec. 2023 (MXN61,260 Mil) to Dec. 2024 (MXN46,175 Mil) but then increased from Dec. 2024 (MXN46,175 Mil) to Dec. 2025 (MXN63,614 Mil).

Thermo Fisher Scientific Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Thermo Fisher Scientific Short-Term Debt Related Terms

Thermo Fisher Scientific Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Thermo Fisher Scientific's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thermo Fisher Scientific Short-Term Debt Chart

Thermo Fisher Scientific Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 52,044.02 108,768.18 61,260.06 46,174.52 63,614.14

Thermo Fisher Scientific Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41,687.85 70,129.88 63,614.14 55,721.04 58,768.23
MEX:TMO
79GF Score
Thermo Fisher Scientific Inc MEX:TMO
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of MXN58,768 Mil mean?
Thermo Fisher Scientific (MEX:TMO) has a Short-Term Debt of MXN58,768 Mil as of Jun. 2026.
Is Thermo Fisher Scientific's Short-Term Debt too high?
Thermo Fisher Scientific's current Short-Term Debt is MXN58,768 Mil. Overall, Thermo Fisher Scientific has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Thermo Fisher Scientific's Short-Term Debt compare to DHR and IDXX?
Thermo Fisher Scientific's Short-Term Debt of MXN58,768 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Diagnostics & Research company?
A good Short-Term Debt depends on the Medical Diagnostics & Research industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Thermo Fisher Scientific's current Short-Term Debt is MXN58,768 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thermo Fisher Scientific stock overvalued right now?
Based on GuruFocus' analysis, Thermo Fisher Scientific (MEX:TMO) is currently considered Fairly Valued. The stock's GF Value™ is MXN10,156.88, compared to a current price of MXN10,254.00 — trading 1% above its estimated fair value. The current Short-Term Debt is MXN58,768 Mil. Thermo Fisher Scientific's overall GF Score™ is 79/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Thermo Fisher Scientific (MEX:TMO), the current Short-Term Debt is MXN58,768 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Thermo Fisher Scientific (MEX:TMO) Overvalued in 2026?

Based on GuruFocus' analysis, Thermo Fisher Scientific stock appears to be overvalued. The current stock price of MXN10,254.00 is trading 1% above its estimated GF Value™ of MXN10,156.88. GuruFocus considers Thermo Fisher Scientific to be Fairly Valued.

Key valuation signals for MEX:TMO:

  • Short-Term Debt: MXN58,768 Mil
  • GF Value™: MXN10,156.88 vs. price of MXN10,254.00 (1% above fair value)
  • GF Score™: 79/100 with 10 warning signs

No single metric tells the full story. See the MEX:TMO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Thermo Fisher Scientific Business Description

Address 168 Third Avenue, Waltham, MA, USA, 02451
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
79GF Score

Get the complete analysis for MEX:TMO

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN10,254.00
Price
MXN10,156.88
GF Value